ロード中...
Ipilimumab in combination with nivolumab for the treatment of renal cell carcinoma
INTRODUCTION: Renal cell carcinoma (RCC) is a highly immunogenic neoplasm, and cytokine-based immunotherapies have been used for decades with limited success. In recent years, antibody-based immunotherapies targeting immune checkpoint receptors PD-1 and CTLA-4 have demonstrated clinical efficacy in...
保存先:
| 出版年: | Expert Opin Biol Ther |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6289271/ https://ncbi.nlm.nih.gov/pubmed/30124333 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14712598.2018.1513485 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|